2007'02.10.Sat
New Treatment a Success for Anaemia Associated With Chronic Kidney Disease
PR
September 14, 2006
-- Not for distribution in the United States
BASINGSTOKE, England, Sept. 14 /Xinhua-PRNewswire/ --
The first anti-anaemia treatment produced in a human cell
line, DYNEPO(R) (epoetin delta), can effectively control
anaemia in patients with chronic kidney disease (CKD[x])
according to two Phase III studies presented for the first
time today.(1),(2)
Patients with kidney disease as a result of diabetes
(diabetic nephropathy) were amongst the population
effectively treated with this new treatment. The data were
presented today at the 42nd Annual Meeting of the European
Association for the Study of Diabetes (EASD).
DYNEPO is the first erythropoiesis-stimulating agent
(ESA) to be produced by gene-activation technology in a
human cell line and accordingly differs from all other
available ESAs, which are all recombinant proteins produced
in Chinese Hamster Ovary cells. The two large-scale Phase
III studies have shown that treatment with DYNEPO can
effectively maintain haemoglobin at target levels (10-12
g/dL) over a long period of time (up to 52 weeks) when
administered by either intravenous or subcutaneous
administration, with the data demonstrating overall
efficacy when DYNEPO was used in various types of patients
with anaemia associated with CKD -- whether they require
dialysis or not.
"Using a human cell line to produce DYNEPO through
activation of the erythropoietin gene is a highly innovative
method," commented Dr. Jonathan Kwan, South West Thames
Renal & Transplantation Unit, St. Helier Hospital, UK.
"Also, because of the increasing trend for less
frequent dosing intervals with ESAs, Shire is initiating a
study to investigate a reduction in the dosing frequency of
DYNEPO. The study will also evaluate the impact of treatment
with DYNEPO on diabetic retinopathy which, together with
diabetic nephropathy, is a serious complication in diabetes
patients."
Diabetic nephropathy is kidney disease that occurs as a
result of diabetes and is the leading cause of kidney
failure in the western world.(3) Approximately two million
people worldwide are undergoing treatment for end stage
renal disease, of which approximately 77% are on
dialysis.(4) In patients with diabetic nephropathy,
anaemia occurs at an earlier stage and is often more severe
than in patients with CKD due to other causes.(5) Anaemia is
also implicated in the development of other microvascular
complications of diabetes.(6)
Dr. Raymond Pratt, Vice President Global Medical
Affairs, Shire said, "The studies underscore the
emerging clinical interest in patients who are not only
suffering from diabetes but also from the many
complications, such as nephropathy, that it can cause.
Shire is committed to meeting the needs of these patients,
and to further investigate DYNEPO's potential for distinct
benefits in these patients."
ABOUT DYNEPO
Erythropoietin is produced in the kidneys and
stimulates the bone marrow to produce more red blood cells
by promoting the development of stem cells into mature red
blood cells. If the kidney starts to fail, patients require
an increase in erythropoietin from a treatment such as
DYNEPO in order to increase red blood cell production. Red
blood cells (erythrocytes) contain haemoglobin and are
vital for oxygen transportation around the body.
Notes to Editors:
SHIRE PLC
Shire's strategic goal is to become the leading
specialty pharmaceutical company that focuses on meeting
the needs of the specialist physician. Shire focuses its
business on attention deficit and hyperactivity disorder
(ADHD), human genetic therapies (HGT), gastrointestinal
(GI) and renal diseases. The structure is sufficiently
flexible to allow Shire to target new therapeutic areas to
the extent opportunities arise through acquisitions. Shire
believes that a carefully selected portfolio of products
with a strategically aligned and relatively small-scale
sales force will deliver strong results.
Shire's focused strategy is to develop and market
products for specialty physicians. Shire's in-licensing and
merger and acquisition efforts are focused on products in
niche markets with strong intellectual property protection
either in the US or Europe.
For further information on Shire (LSE: SHP), please
visit the Company's website: http://www.shire.com .
References
1. M Smyth, KJ Martin, RP Pratt. Epoetin delta
(Dynepo(R)), erythropoietin produced by a human cell line,
is as effective as epoetin alfa in patients with renal
anaemia, including those with diabetic nephropathy. Poster
presented at the 42nd Annual Meeting of the European
Association for the Study of Diabetes (EASD), 14-17
September 2006, Copenhagen-Malmoe, Denmark-Sweden.
2. JTC Kwan, M Smyth, RD Pratt. Human cell line derived
erythropoietin (epoetin delta, Dynepo(R)) administered
subcutaneously is effective in the management of anaemia
associated with chronic kidney disease. Poster presented
at the 42nd Annual Meeting of the European Association for
the Study of Diabetes (EASD), 14-17 September 2006,
Copenhagen-Malmoe, Denmark-Sweden.
3. Russell TA. Diabetic nephropathy in patients with
type 1 diabetes mellitus. Nephrol Nurs J 2006; 33(1):
15-28.
4. Grassmann A, Gioberge S, et al. ESRD patients in
2004: global overview of patient numbers, treatment
modalities and associated trends. Nephrol Dial Transplant
2005; 20: 2587-2593.
5. Stevens PE, O'Donoghue DJ, Lameire NR. Anaemia in
patients with diabetes: unrecognised, undetected and
untreated? Curr Med Res Opin 2003; 19 (5): 395-401.
6. Thomas MC, Cooper ME, Rossing K, Parving HH. Anaemia
in diabetes: is there a rationale to TREAT? Diabetologia
2006 Jun; 49(6):1151-1157.
[x] CKD is sometimes referred to as chronic renal
failure (CRF).
For more information, please contact:
Media Shire, Jessica Mann, +44(0)1256-894-280; Media
PR agents for DYNEPO, Resolute Communications,
+44(0)20-7357-8187, Lizzy Ray; Media PR agents for Resolute
Communications; DYNEPO, Dr Marilyn Ewan, +44(0)20-7357-8187
SOURCE Shire plc
2007'02.10.Sat
MEDIA ADVISORY: The Secretary-General -- Message on the International Day for the Preservation of the Ozone Layer
September 14, 2006
-- EMBARGO UNTIL 16 SEPTEMBER 2006 --
The Secretary-General of the UN addresses a speech on
International Day for the Preservation of the Ozone Layer,
16 September. Details of the speech follow:
"The Montreal Protocol on Substances that Deplete
the Ozone Layer is effective and working. Since the entry
into force of this multilateral environmental agreement,
there has been tremendous progress in global efforts to
repair the ozone layer. As a consequence, there are now
early signs that we are on the road to recovery of this
precious life-support system."
"In the latest of a series of scientific
assessments conducted under the auspices of the World
Meteorological Organisation (WMO) and the UN Environment
Programme (UNEP), more than 300 scientists from 34
countries of the developed and developing world have found
clear evidence of a decrease in the abundance of
ozone-depleting substances in the lower atmosphere, as well
as indications that their destructive impact in the
stratosphere has also started to decline."
"Improved chemistry-climate modelling used in the
assessments has given us a more accurate estimate of the
expected dates for total ozone layer recovery. In the
mid-latitudes and the Arctic, recovery is now anticipated
around 2049, five years later than was previously
estimated. In Antarctica, recovery is expected by about
2065, fifteen years later than the previous
estimate."
"The assessment's findings are solid evidence that
the international community's has delivered on its promises.
As noted by the eminent scientists in the assessment
report, however, failure to comply with the Protocol would
delay or could even prevent recovery of the ozone layer. I
therefore urge all countries to reaffirm their commitment to
implementation. The work is still unfinished, and it is
only through persistent dedication over the course of this
century that our generation and future generations will
realize the benefits of full ozone layer recovery."
"The theme of this year's observance,
"Protect the Ozone Layer: Save Life on Earth",
invites the international community to build on its
achievements to date by accelerating the phase-out of ozone
depleting substances. I appeal to Governments, in
partnership with industry, non-governmental organizations
and citizens all over the world, to celebrate this year's
International Day for the Preservation of the Ozone Layer
by promoting activities that will continue to sustain
public and political awareness until the task is fully
accomplished."
For more information, please contact:
Ms. Zhang Wei,
Media Officer,
UNDP China
Tel: +86-10-8532-0715
Email: wei.zhang@undp.org
SOURCE United Nations Development Programme
2007'02.10.Sat
Atmel Introduces a Cost-Optimized Smart Card Reader IC for USB Keyboards
September 14, 2006
NANTES, France, Sept. 14 /Xinhua-PRNewswire/ --
Atmel(R) Corporation (Nasdaq: ATML) announced today the
release of the AT83C22OK106, a smart card reader product
targeting USB smart card keyboard. The AT83C22OK106 was
developed in partnership with OMNIKEY(R), a major smart
card reader manufacturer.
The new AT83C22OK106 is an updated and optimized
version of the previous AT83C22OK. It includes 8051 core,
USB interface, and ISO7816 UART smart card interface, as
well as a high-efficiency DC/DC converter. Therefore, it is
compliant with the major smart card standards such as EMV
& PC/SC. It supports 5 V, 3 V and 1.8 V cards
regardless of the input voltage. The AT83C22OK106 is
designed to provide a solution for a reader system with
only a few additional external components mounted on a
single sided PCB.
Arnaud Ruchon, Product Marketing Manager for Smart Card
Reader ICs at Atmel stated, "The AT83C22OK106, combined
with the state-of-the-art firmware developed by OMNIKEY, is
a unique solution for keyboard manufacturers. It allows
them to implement a keyboard with smart card functionality
in less than two weeks." He added, "Thanks to
its optimized size, the AT83C22OK106 allows us to be even
more price competitive."
The firmware supports all types of smart cards with
high baud rates up to 433 kbits/s with full CCID
compatibility and includes BIOS support. Keyboards up to
160 keys using any OEM specific keyboard matrix are
supported. Furthermore, the firmware features a common
criteria certified secure PIN-entry functionality.
According to Kurt Schmid, Chief Executive Officer from
OMNIKEY, "Thanks to its complete set of features and
its reduced price, the new version of the AT83C22OK will
help to win new smart card reader businesses in the
keyboard area. Atmel and OMNIKEY partnership offers the
best solutions for the keyboard OEM market."
Pricing and Availability
The AT89RFD-02 reference design kit is available, for
$250, to facilitate a PCB design. Included is a reference
board, software, and all required documentation.
The AT83C22OK is available now in QFP64 and QFN64
packages. Pricing in 10k unit-quantities is $ 2.60 USD.
About Atmel
Atmel is a worldwide leader in the design and
manufacture of microcontrollers, advanced logic,
mixed-signal, nonvolatile memory and radio frequency (RF)
components. Leveraging one of the industry's broadest
intellectual property (IP) technology portfolios, Atmel is
able to provide the electronics industry with complete
system solutions. Focused on consumer, industrial,
security, communications, computing and automotive markets,
Atmel ICs can be found Everywhere You Are(R).
NOTE: Atmel(R), logo and combinations thereof,
Everywhere You Are(R) and others, are registered
trademarks, or trademarks of Atmel Corporation or its
subsidiaries. Other terms and product names may be
trademarks of others.
Information:
Atmel's AT83C22OK106 product information may be
retrieved at
http://www.atmel.com/dyn/products/product_card.asp?PN=AT83C22OK
.
For further information on smart card readers, go to
http://www.atmel.com/products/scr .
For more information, please contact:
Philippe Faure,
Marketing Communications Manager -- Microcontrollers
Tel: +33-2-40-181-887
Email: philippe.faure@nto.atmel.com
Helen Perlegos,
Public Relations -- USA and Asia Pacific Rim,
Tel: +1-408-487-2963
Email: hperlegos@atmel.com
Veronique Sablereau,
Corporate Communications Manager -- Europe
Tel: +33-1-30-607-068
Fax: +49-7-13-167-2423
Email: veronique.sablereau@atmel.com
SOURCE Atmel Corporation
2007'02.10.Sat
Otis Wins Record Order in Kuwait
September 13, 2006
FARMINGTON, Conn., Sept. 13 /Xinhua-PRNewswire/ -- Otis
Elevator Company, a unit of United Technologies Corp. (NYSE:
UTX), has won a contract to supply and install 90 escalators
and 48 Gen2(R) Comfort elevators for a 1.6
million-square-foot mall project in Al-Ardiya, Kuwait. The
order, Otis' largest to date in Kuwait, follows an order
earlier this year for 42 Gen2(R) elevators in Kuwait City.
"Otis continues to strengthen its presence in
Kuwait due to our experienced local management team as well
as our comprehensive installation and service
capabilities," said Ari Bousbib, Otis president.
"We look forward to this partnership with Al-Waseela
Real Estate Company and to our participation in this
important retail project."
The Al-Ardiya project will support small industries and
handcrafts. It includes a central area with individual
studio workshops surrounded by a showroom and mall where
handcrafts can be displayed and sold.
Otis' Gen2 Comfort elevator brings the same
unparalleled energy savings, reliability and quiet,
environment-friendly operation of the Gen2 family of
elevators to the low-rise residential and small-scale
commercial building market segments. It can carry loads of
320 kilograms (four people) to 1,000 kilograms (13 people)
at speeds of up to one meter per second.
Otis Elevator Company is the world's largest
manufacturer and maintainer of people-moving products,
including elevators, escalators, and moving walkways. With
headquarters in Farmington, Connecticut, Otis employs 60,000
people, offers products and services in more than 200
countries and territories and maintains 1.5 million
elevators and escalators worldwide. United Technologies
Corp., based in Hartford, Connecticut, is a diversified
company providing high technology products and services to
the building and aerospace industries.
For more information, please contact:
Tizz Weber
Director, Communications
Tel: +1-860-676-6127
Email: Tizz.Weber@Otis.com
SOURCE Otis Elevator Company
2007'02.10.Sat
New EASD/ADA Consensus Recommends Metformin (Glucophage(R)) at Diagnosis of Type 2 Diabetes
September 13, 2006
COPENHAGEN, Denmark, Sept. 13 /Xinhua-PRNewswire/ --
Newly diagnosed patients with diabetes should be treated
with metformin (Glucophage(R)) in conjunction with
lifestyle modification (unless metformin is
contraindicated). Initiation of metformin should no longer
be delayed until lifestyle modification (weight loss and
increased activity) fails to adequately control glycaemia.
This is the recommendation of a new consensus statement from
the American Diabetes Association (ADA) and the European
Association for the Study of Diabetes (EASD)(1).
Traditionally, guidelines have recommended lifestyle
modification as the first step in intervention to reduce
glycaemia. Oral antidiabetic treatment should be initiated
with metformin, according to guidelines published by the
International Diabetes Federation (IDF) in 2005. These
guidelines stated that: "Standard care should begin
with metformin unless there is evidence or risk of renal
impairment."(2)
Now, however, the ADA/EASD expert panel has recognised
that lifestyle modification alone often fails to achieve or
maintain metabolic goals. Therefore, most patients will also
require effective treatment with metformin (Glucophage).
Thus, the added benefits of metformin (Glucophage) should
not be delayed after diagnosis.
Dr Clifford Bailey, Professor of Clinical Science at
Aston University, Birmingham, UK, and a member of the EASD
committee that reviewed the new treatment algorithm, said:
"Metformin is widely available and efficacious in
long-term glycaemic control. The recommendation of
metformin at diagnosis of type 2 diabetes is not a major
variation from many other treatment algorithms, but is
noteworthy in that it appears for the first time in an
international consensus guideline."
Metformin (Glucophage) is recommended because it has
demonstrated:
-- Typical lowering of HbA1c by 1.5-2.0% according to
dosage
-- Absence of weight gain and hypoglycaemia
-- Generally low level of side effects
-- High level of acceptance by patients
-- Relatively low cost
Additionally, the landmark United Kingdom Prospective
Diabetes Study (UKPDS) demonstrated that metformin
significantly reduced the risk of fatal and non-fatal
cardiovascular events in patients with type 2 diabetes(3).
The study showed a 36% reduction in all-cause mortality, a
42% reduction in diabetes-related mortality and a 32%
reduction in diabetes-related endpoints.
Following initiation of treatment, the expert group
recommends that metformin (Glucophage) should be titrated
to the maximum effective and tolerated dose over one to two
months. Only after this is achieved should another agent be
added if required to achieve glycaemic goals.
References
1. Nathan DM, Buse JB, Davidson MB et al. Management of
hyperglycaemia in
type 2 diabetes: a consensus algorithm for the
initiation and
adjustment of therapy. A consensus statement from
the American Diabetes
Association and the European Association for the
Study of Diabetes.
Diabetologia 2006; 49: 1711-1721 and Diabetes Care
2006; 29: 1963-1972.
2. International Diabetes Federation 2005. Clinical
Guidelines Task Force.
Global guideline for type 2 diabetes. Available from
http://www.idf.org
3. UKPDS Group. Effect of intensive blood glucose
control with metformin
on complication in overweight patients with type 2
diabetes (UKPDS 34).
Lancet 1998; 352: 854-65.
Note to Editors
-- This is the first international treatment algorithm
of hyperglycaemia in type 2 diabetes to recommend
simultaneous initiation of pharmaceutical therapy and
lifestyle intervention in newly diagnosed patients.
-- The recommendations were reviewed and approved by
the Professional Practice Committee of the American
Diabetes Association and by an ad hoc committee of the
European Association for the Study of Diabetes (U Smith,
Gothenburg, Sweden; S Del Prato, Pisa, Italy; C Bailey,
Birmingham, UK; and, B Charbonnel, Nantes, France).
About Merck CardioMetabolic Care
Merck's commitment to cardiometabolic care stretches
back for more than four decades, since the introduction of
Glucophage(R)(x) into clinical practice. Merck is the
global market leader in oral diabetes medications. Most
patients with type 2 diabetes in over 100 countries around
the globe currently benefit from various products based on
metformin. In addition, Merck is offering the
lipid-modifying drug Niaspan(R) (prolonged release
nicotinic acid) with a particularly strong HDL-raising
effect that is intended to be used in patients with
dyslipidaemia; the Concor(R) product family which offers
treatment for hypertension, coronary artery disease and
chronic heart failure and other cardiovascular products
available in various countries.
(x) Glucophage(R) is also marketed under the following
brand names: Diabex(R), Dabex(R), Dianben(R), Glifage(R),
Glisulin(R), Merckformin(R) and Risidon(R)
Merck is a global pharmaceutical and chemical company
with sales of EUR 5.9 billion in 2005, a history that began
in 1668, and a future shaped by 29,958 employees in 55
countries. Its success is characterized by innovations from
entrepreneurial employees. Merck's operating activities come
under the umbrella of Merck KGaA, in which the Merck family
holds a 73% interest and free shareholders own the
remaining 27%. In 1917 the U.S. subsidiary Merck & Co.
was expropriated and has been an independent company ever
since.
For more information, please contact:
Harry Howlett
PhD FRCP
International Medical Adviser
Tel: +44-189-545-2231
Jean-Christophe Valluy
International Marketing Manager
Tel: +33-4-72-78-28-21
Isabella Schmele
Tel: +49-6151-72-5475
SOURCE Merck KGaA
2007'02.10.Sat
Global Spending on Visa Business Cards Reaches $190 Billion for Past 12 Months
September 13, 2006
Milestone Achievement Demonstrates Small Business Shift to Electronic Payments For Better Cash Flow Management
SAN FRANCISCO, Sept. 13 /Xinhua-PRNewswire/ -- Visa
International today announced that the sales volume of Visa
Business cards worldwide, represented by global small
business spend, has reached US$190 billion over a 12-month
period, as small businesses continue to adopt payment
solutions that are more convenient and secure than cash and
checks.
For the four quarters ended June 30, 2006, small
businesses worldwide made US$190 billion in purchases with
their Visa Business cards, representing a compound annual
growth rate of 32 percent. Visa Business is leading the
growth within Visa Commercial, and is one of the fastest
growing product segments for financial institutions.
"Small business owners worldwide want efficient
payment and information solutions that help streamline cash
flow and expense management so they can concentrate on
growing their businesses," said Preet Chhokar, vice
president, Visa Commercial, Visa International.
"Reaching this milestone is a testament to the
advantages Visa Business provides small businesses over
cash and checks."
The potential for the growth of electronic payments is
significant. Using the Commercial Consumption Expenditure
(CCE) index, Visa International estimates that global
business and government spending, excluding payroll and
certain other capital expenditures, totaled nearly US$61
trillion in 2005.
Small business CCE can represent upwards of 25 percent
of total CCE, varying by country. One-third of this
business spending could potentially be moved from cash to
electronic payment systems, such as Visa Business
products.
To help Visa member financial institutions tap into
this opportunity, Visa recently published the Visa Business
Expedition Pack, a 10-step program that offers advice on how
to manage small business credit risk. Visa recently launched
the program during a series of member workshops designed to
help financial institutions anticipate lending obstacles,
meet risk management challenges, and make proactive changes
to implement successful small and medium-sized enterprise
(SME) payment programs.
Six member workshop sessions were hosted in the
sub-Saharan Africa Region. In addition, in Singapore, more
than 75 delegates benefited from a focused credit risk
workshop during a Commercial Leadership Forum. In Colombia,
more than 60 individuals representing 19 different financial
institutions found the workshops highly valuable. "This
seminar gave me concrete and relevant tools that will help
me better serve the payment needs of my small business
customers," said Adriana Marcela Rivas Ramirez,
general manager, Bank of Bogota.
Additional sessions are planned in Asia Pacific,
Central Europe, Latin America, and Europe throughout the
year. For more information, please contact a Visa regional
representative.
Visa Business provides flexible payment solutions for
small businesses. Small business owners can use Visa
Business payment solutions to efficiently manage cash flow,
separate business and personal expenses, streamline
payments, and gain visibility into daily business spend.
Visa Business also lowers costs by reducing manual
paper-based purchase order processes, enabling negotiations
with preferred suppliers and providing access to discounts.
Notes to Editors:
About Visa Commercial: Visa Commercial payment
solutions -- Visa Business, Visa Corporate, Visa
Purchasing, and Visa Commerce -- combine payment with
information to create intelligent payment solutions that
enable business and government organizations of any size
and type to reduce costs, streamline operational and
payment processes, and make more informed business
decisions.
Backed by Visa's unsurpassed acceptance and utility,
Visa Commercial products and services provide the most
complete way to manage payment-related processes, including
travel and entertainment and procurement expenditures,
payroll distribution, and information management. For more
information, visit http://www.visa.com/visacommercial.
About Visa: Visa connects cardholders, merchants and
financial institutions through the world's largest
electronic payments network. Visa products allow buyers and
sellers to conduct commerce with ease and confidence in both
the physical and virtual worlds. As an association owned by
20,000 member financial institutions, Visa is committed to
the sustained growth of electronic payment systems to
support the needs of all stakeholders and to drive economic
growth. For more information, visit
http://www.corporate.visa.com .
For more information, please contact:
Sabine Middlemass,
Visa International
Tel: +1-650-432-8307
Email: globalmedia@visa.com
Ingrid Faroyvik,
Burson-Marsteller
Tel: +1-310-309-6657
Email: ingrid.faroyvik@bm.com
SOURCE Visa International
2007'02.10.Sat
Digi High Speed Wireless WAN Router Receives Certification on Verizon Wireless EV-DO Network
September 13, 2006
ConnectPort WAN VPN is Industry's First Upgradeable, Commercial-grade 3G Wireless WAN Router
MINNETONKA, Minn., Sept. 13 /Xinhua-PRNewswire/ -- Digi
International (Nasdaq: DGII) today announced that its
ConnectPort WAN VPN is now certified by Verizon Wireless
for use on its high speed EV-DO network. The ConnectPort
WAN VPN is the first commercial grade, upgradeable, 3G
wireless wide area network (WWAN) router that provides a
secure, high-speed WWAN connection for reliable primary and
backup network connectivity to remote sites and devices.
Because the solution is modular, it is upgradeable, making
it easier for customers to quickly migrate to future
advanced platforms as networks evolve. Verizon Wireless'
EV-DO network gives customers high-speed access to
corporate data, device information, and the Internet
anywhere within the coverage area at download speeds
averaging 400 to 700 kbps. Customers outside of the EV-DO
coverage area will seamlessly switch to Verizon Wireless'
1xRTT network to remain connected while on the road.
Using the ConnectPort WAN VPN with its integrated
Sierra Wireless MC5720 PCI Express Mini Card embedded
module, customers can deploy on Verizon Wireless'
EV-DO-1xRTT Rev 0 network today and can upgrade to
EV-DO-1xRTT Revision A when it becomes available, by
replacing the wireless module. The ConnectPort WAN VPN is
the only Verizon Wireless-certified commercial grade
solution to provide this level of flexibility. The PCI
Express Mini Card module is easy to upgrade, like a PCMCIA
card, but is a superior choice for rugged commercial
applications because of its smaller, fully enclosed form
factor.
The ConnectPort WAN VPN offers an easy and
cost-effective means of connecting virtually any remote
location into the corporate IP network at broadband-like
speeds. It is ideal for use where wired networks are not
feasible or where alternative network connections are
required. It can be managed locally via a built-in web
interface or remotely using Digi Connectware(R) Manager,
the industry's only enterprise class remote device
management software for Wireless WAN applications. For a
complete list of carriers and more information about the
ConnectPort WAN VPN, visit
http://www.digi.com/products/wireless/connectportwanvpn.jsp
.
About Digi International
Digi International, based in Minneapolis, makes device
networking easy by developing products and technologies
that are cost effective and easy to use. Digi markets its
products through a global network of distributors and
resellers, systems integrators and original equipment
manufacturers (OEMs).
For more information, please contact:
Digi International
Lucy Hou
Marketing Communication Specialist, China
Tel: +86-10-6561-8310-12
Fax: +86-10-6561-8152
SOURCE Digi International
2007'02.10.Sat
SMIC Denies Allegations and Files Cross-Complaint Against TSMC
September 13, 2006
SHANGHAI, China, Sept. 13 /Xinhua-PRNewswire/ --
Semiconductor Manufacturing International Corporation
(NYSE: SMI; SEHK: 981) ("SMIC" or the
"Company") announced today that in addition to
filing a response strongly denying the allegations of
Taiwan Semiconductor Manufacturing Company Ltd
("TSMC") in the United States lawsuit, SMIC filed
a Cross-Complaint against TSMC, seeking, amongst other
things, damages for TSMC's breach of contract and breach of
implied covenant of good faith and fair dealing.
In the Cross-Complaint, SMIC sets out in detail the
background of why SMIC's leading role in Mainland China
poses a substantial threat to competitors like TSMC. It
describes how TSMC, rather than compete in the marketplace,
has undertaken a concerted effort since the previous
lawsuits to discredit SMIC by making unfair and misleading
accusations; how SMIC takes its obligations under the
Settlement Agreement seriously and fully complied with the
agreement; how TSMC did not voice any complaint for a
period of over 17 months, until July 2006, after SMIC
succeeded in meeting a number of major business and
technical milestones during Q2 2006; how TSMC failed to
negotiate or act in good faith, and how TSMC used the
lawsuit and subsequent campaign to repeat its previous
campaign to disrupt SMIC's business and valued
relationships with its customers.
SMIC will vigorously pursue the Cross-Complaint and the
defence to TSMC's lawsuit in order for the California court,
upon full consideration of all evidence, to dismiss TSMC's
claims and grant judgment in favour of SMIC. SMIC would
like to thank its customers, partners, investors and other
friends for their support to SMIC and reassure them that
this lawsuit will not distract it from its mission to
provide world class technologies and services and to
achieve outstanding and rewarding performance, and its
commitment to play a constructive role in the semiconductor
industry. SMIC welcomes fair competition and participation
by other companies in the development of Mainland China
semiconductor industry, and urges TSMC to act fairly and
reasonably.
About SMIC
SMIC (NYSE: SMI; SEHK: 981) is one of the leading
semiconductor foundries in the world and the largest and
most advanced foundry in Mainland China, providing
integrated circuit (IC) manufacturing service at 0.35mm to
90nm and finer line technologies. Headquartered in
Shanghai, China, SMIC operates three 200mm fabs in Shanghai
and one in Tianjin, and one 300mm fab in Beijing, the first
of its kind in Mainland China. SMIC has customer service
and marketing offices in the U.S., Italy, and Japan as well
as a representative office in Hong Kong. For additional
information, please visit http://www.smics.com .
For more information, please contact:
SMIC Shanghai
Reiko Chang
SMIC Public Relations Department
Tel: +86-21-5080-2000 x10544
E-mail: PR@smics.com
SMIC Hong Kong
Mei Fung Hoo
Tel: +852-2537-8480
Email: MeiFung_Hoo@smics.com
Strategic Financial Relations Limited
Veron Ng
Tel: +852-2864-4831
Email: veron@strategic.com.hk
Joanne Lam
Tel: +852-2864-4816
Email: joanne@strategic.com.hk
SOURCE Semiconductor Manufacturing International
Corporation
2007'02.10.Sat
Empower Farmers with Innovative Technologies to Build the Socialist New Countryside
September 13, 2006
-- UNDP Teams Up With Government Agencies to Developing Market-oriented Mechanisms to Link Farmers to Innovative Technologies and Expertise to Increase Their Income and Promote Sustainable Rural Development
ULUMUQI, China, Sept. 13 /Xinhua-PRNewswire/ -- The
United Nations Development Programme (UNDP), the Ministry
of Science and Technology (MOST), and the China
International Center for Economic and Technical Exchanges
(CICETE) under the Ministry of Commerce reached an
agreement today in Ulumuqi, Xinjiang to scale up a joint
initiative to link farmers with innovative technologies.
Entitled "Alleviating Rural Poverty through
Innovative Technologies Transfer," the four-year
project is designed to link farmers with innovative,
environmentally-friendly technologies in order to increase
their income and promote sustainable rural development.
Launched in April 2006 with the initial fund of US$4
million (US$1 million from UNDP and US$3 million from
MOST), the project was designed to support China's
Technical Task Forces (TTFs) initiative to become critical
part of a diverse rural technical extension system with
market-oriented structure to meet different needs of
farmers, farm systems and rural communities.
UNDP, CICETE and MOST signed today an agreement on the
increase of US$ 3.4 million for the project, of which
US$480,000 will be contributed by UNDP, US$2.4 million by
MOST, and US$520,000 by Stora Enso, a multinational company
of paper products based in Europe.
"I am delighted to know that representatives from
15 provinces will sign agreements with the Ministry of
Science and Technology to implement this project,"
said Khalid Malik, UN Resident Coordinator and UNDP
Resident Representative in China. "With your great
commitment and contribution I believe we will not only help
farmers develop new business models to increase their income
but also assist China in establishing new models of
industrialization to sustain its high growth rate," he
added.
He emphasized that the project was very timely as it is
closely connected to the Government's commitment to build
the socialist new countryside by applying scientific
development approaches.
"UNDP is the first international development
organization that work with MOST to further develop and
enhance TTFs," said Liu Yanhua, Vice Minister of the
MOST, adding that since 2002, a total of 598 counties in 24
provinces currently pilot the new market-oriented mechanism,
known as TTF, by providing farmers with new technologies and
skills for better livelihoods. According to Liu, 23,000 TTF
practitioners were dispatched and 5.84 million farmers
received technical training in 2005.
"It is hoped that this initiative will bring TTFs
to a higher level by emphasizing balance between economic
growth, social development and environmental protection to
promote sustainable development in rural China," he
added.
Under the project, 30 counties are selected from 15
provinces and autonomous regions. Among them, six
provinces: Fujian, Zhejiang, Guangxi, Inner Mongolia,
Ningxia and Xinjiang, are identified as key pilot provinces
to develop experimental TTF models to be shared at the
national level.
UNDP fosters human development to empower women and men
to build better lives in China. As the UN's development
network, UNDP draws on a world of experience to assist
China in developing its own solutions to the country's
development challenges. Through partnerships and
innovation, UNDP works to achieve the Millennium
Development Goals and an equitable Xiao Kang society by
reducing poverty, strengthening the rule of law, promoting
environmental sustainability, and fighting HIV/AIDS.
http://www.undp.org.cn
For more information, please contact:
Ms. Zhang Wei,
Communications Officer,
UNDP China
Tel: +86-10-8532-0715
Email: wei.zhang@undp.org
SOURCE United Nations Development Programme
2007'02.10.Sat
Akrion Signs SCP Global Technologies Deal
September 13, 2006
Company Will Support SCP's Batch Installation Base
ALLENTOWN, Pa., Sept. 13 /Xinhua-PRNewswire/ -- Akrion,
Inc. today announced that it has entered into an agreement,
subject to certain conditions, to acquire most of the
assets and selected liabilities of SCP Global Technologies,
Inc. (SCP), a manufacturer of batch-immersion tools based in
Boise, Idaho.
This transaction is the next step in Akrion's on-going
strategy to become the pre-eminent supplier of surface
preparation equipment to the semiconductor industry.
Akrion offers solutions for all semiconductor manufacturing
process nodes. Products for batch immersion cleaning (>
90nm design rules) include the high-quality, highly
reliable and flexible modular GAMA(TM) Series and
i-Clean(TM) systems. For leading edge devices, 90-45nm,
Akrion offers Goldfinger(TM) single-wafer cleaning systems
for 200 and 300mm FEOL and BEOL applications.
Upon closing of the SCP acquisition, Akrion will
provide tools, spare parts, service, enhancements and
product upgrades to former SCP and Steag-AWP wet station
customers for their extensive base of batch tools
worldwide.
James S. Molinaro, Akrion President and CEO said,
"The semiconductor capital equipment market continues
to consolidate and Akrion continues to lead the charge. We
intend to enhance and maintain the SCP and Steag-AWP
installed base of batch process systems worldwide, as we do
with our GAMA(TM), i-Clean(TM), V3(TM) and Goldfinger(TM)
systems. That is, we intend to provide unsurpassed
service, spare parts and upgrades to all of our customers
and we welcome "SCP" system owners to our
"extended family."
About Akrion
Akrion is a leading provider of single-wafer and
batch-immersion cleaning systems for the semiconductor
industry. The company's products are used in the production
of a diverse range of semiconductor and related devices,
including integrated circuits for DRAM, Flash, Logic and
micro-electrical mechanical systems (MEMS) and photomasks.
Headquartered in Allentown, Pa., Akrion's Allentown
production facility is ISO 9001:2000 and ISO 14001:2004
certified. The company Web site is located at
http://www.akrion.com .
For more information, please contact:
Alan Walter of Akrion, Inc.
Tel: +1-610-530-3698
SOURCE Akrion, Inc.
2007'02.10.Sat
FARO Laser Trackers Dominate Global Market
September 13, 2006
LAKE MARY, Fla., Sept. 13 /Xinhua-PRNewswire/ -- FARO
Technologies, Inc., the world's single source for a
complete line of portable CAM2 solutions, has officially
established itself as the worldwide market leader in laser
tracker sales.
The Company's next largest competitor's recent press
release showed that they shipped more than 400 units in
approximately three years. In that same time frame, FARO
shipped over 600 Laser Trackers - outselling the other
brand by 50 percent. The third-place competitor may have
sold fewer than 75 in the same time period.
"Market demand is clearly shifting toward FARO
Laser Trackers," FARO President and Co-CEO Jay
Freeland said. "To date, sales continue to remain
strong, and we are well on pace to produce our 1,000th unit
by October 2006. This is a considerable achievement and
testament to the growing reputation of the Tracker's
state-of-the-art technology."
In addition to growing its market share in the
automotive and heavy equipment industries, FARO logged
major contracts with aerospace giants Boeing and Airbus, as
well as their respective subsidiaries and OEM suppliers.
Freeland credits the FARO Tracker's popularity with its
unique features that increase productivity, including
automatic warm-up and compensation routines. Also of
benefit is the fact that FARO is the first manufacturer to
conform to the ASME B89.4.19 Standard for laser tracker
performance, and is the only manufacturer with an ISO-17025
accreditation based on this procedure.
The FARO Laser Tracker is a portable, computerized
measurement device that creates a 3-D "blueprint"
of large objects and parts up to 230 feet in size. As the
user guides a mirrored target over the object's entire
surface, the Tracker emits a laser beam that is reflected
back from the target, allowing the system's laptop computer
to simultaneously draw and record all of its 3-D
measurements with up to .001" accuracy. The Tracker
can also take automatic measurements by steering the laser
to multiple targets positioned on the object.
Engineers and designers use the data to
reverse-engineer, improve or create new parts and products
-- or improve how they're made. Quality control personnel
use it to verify that the parts have been made correctly,
and, if not, where they need to be corrected.
The FARO Tracker's portability and advanced technology
allow users to increase production efficiency while
decreasing time-to-market, scrap, and re-work costs by
measuring on the production shop floor, design room, or
anywhere it's convenient.
For more information visit http://www.faro.com .
About FARO
With approximately 12,500 installations and 5,500
customers globally, FARO Technologies, Inc. (Nasdaq: FARO)
and its international subsidiaries design, develop, and
market software and portable, computerized measurement
devices. The Company's products allow manufacturers to
perform 3-D inspections of parts and assemblies on the shop
floor. This helps eliminate manufacturing errors, and
thereby increases productivity and profitability for a
variety of industries in FARO's worldwide customer base.
Principal products include the Platinum, Titanium,
Advantage, and Digital Template FaroArms; the FARO Gage,
Gage-PLUS and PowerGAGE; the FARO Laser ScanArm; the FARO
Laser Tracker X and Xi; the FARO Laser Scanner LS; and the
CAM2 family of advanced CAD-based measurement and reporting
software. FARO Technologies is ISO-9001:2000 certified, and
accredited to ISO-17025 Calibration Laboratory Standard.
This press release contains forward-looking statements
(within the meaning of the Private Securities Litigation
Reform Act of 1995) that are subject to risks and
uncertainties, such as statements about our plans,
objectives, projections, expectations, assumptions,
strategies, or future events. Statements that are not
historical facts or that describe the Company's plans,
objectives, projections, expectations, assumptions,
strategies, or goals are forward-looking statements. In
addition, words such as "may,"
"believes," "anticipates,"
"expects," "intends,"
"plans," "seeks,"
"estimates," "will,"
"should," "could,"
"projects," "forecast," and similar
expressions or discussions of our strategy or other
intentions identify forward-looking statements. Other
written or oral statements, which constitute
forward-looking statements, also may be made by the Company
from time to time. Forward-looking statements are not
guarantees of future performance and are subject to various
known and unknown risks, uncertainties, and other factors
that may cause actual results, performances, or
achievements to differ materially from future results,
performances, or achievements expressed or implied by such
forward-looking statements. Consequently, undue reliance
should not be placed on these forward-looking statements.
Factors that could cause actual results to differ
materially from what is expressed or forecasted in
forward-looking statements include, but are not limited
to:
-- unforeseen issues affecting the Company's ability
to produce laser
trackers at its various facilities.
Forward-looking statements in this release represent
the Company's judgment as of the date of this release. The
Company undertakes no obligation to update publicly any
forward-looking statements, whether as a result of new
information, future events, or otherwise.
For more information, please contact:
Darin Sahler,
Global PR Manager,
FARO Technologies, Inc.
Tel: +1-407-333-9911
Email: Darin.Sahler@faro.com
SOURCE FARO Technologies, Inc.
2007'02.10.Sat
Atticus Capital LP Opposes Genzyme Bid for AnorMED
September 13, 2006
NEW YORK, Sept. 13 /Xinhua-PRNewswire/ -- Atticus
Capital LP does not support Genzyme Corporation's (GENZ)
bid for AnorMED Inc. (ANOR), believing that it is not in
the best interest of shareholders. "We think the
Genzyme bid undervalues the company, and support the
efforts of AnorMED and its advisors to seek better
alternatives," stated an Atticus spokesman.
Atticus Capital currently owns 9.1% of the outstanding
shares of AnorMED.
For more information, please contact:
Robert Coburn of Atticus Capital LP
Tel: +1-212-373-0800
SOURCE Atticus Capital LP
2007'02.10.Sat
Buongiorno, Sharp Growth for the First Half of 2006: EBITDA increased 173% Compared to 2005
September 13, 2006
MILAN, Italy, Sept. 13 /Xinhua-PRNewswire/ -- The Board
of Directors of Buongiorno S.p.A. (MTAX STAR, Borsa
Italiana: BNG), a multinational operating in the market of
digital entertainment, approved today the figures for the
first quarter 2006.
Value of Production for H1 2006 grew by 68% compared to
the same period of 2005, thus increasing from Euro 58.9
million to Euro 99.2 million. Core business revenues for
the first half of 2006 increased 70% compared to the
previous year, reaching Euro 98.3 million.
The geographical breakdown shows that the sharp
increase in revenues was driven by the US, where sales
increased over 6 times from Euro 4.9 million in 2005 to
Euro 33.4 million in 2006. Growth was also sustained in the
Iberian Peninsula and South America (+26%). Revenues in
central Europe also increased 30% year-on-year, boosted by
acquisitions made in the second half of 2005. The Group's
objective of geographically diversifying its revenues has
now been completely achieved with the balanced mix among
the various regions.
In the first six months of 2006, the Group continued in
its internationalization process, setting up subsidiaries in
Turkey, Brazil, Bolivia, Ecuador, Peru, Colombia and Chile.
Furthermore, in August, the Group's US subsidiary acquired
the US company Rocket Mobile and Mr. Fernando Gonzales
Mesones assumed responsibility for North America, Latin
America, and the Iberian peninsula.
In terms of business lines, the most significant share
of core business revenues was represented by revenues from
Consumer Services, that grew 95% compared to the same
period in 2005, rising from around Euro 47 million to Euro
91.5 million, thus accounting for 93% of total revenues in
H1 2006. Marketing Services revenues dropped 37% from Euro
10.9 million in H1 2005 to approximately Euro 6.8 million in
the same period of 2006. This decrease is consistent with
the Group's strategic decision to focus only on several
specific operations, relationship marketing in particular.
Industrial Added Value calculated as core business
revenues minus the variable cost of sales and marketing
expenses, was approximately Euro 36 million in the six
months, up about 62% compared to Euro 22.1 million in the
same period of the prior year.
The complete press release is available at
http://www.buongiorno.com/investors/investors_4.html .
For more information, please contact:
Monica Montefusco,
Global PR & Events Manager
Tel: +39-0258-2131
Email: monica.montefusco@buongiorno.com
SOURCE Buongiorno Vitaminic SPA
2007'02.10.Sat
TCOM Announces Subaye.com to Develop Corporate Video Sharing Channel to Provide IBS v5.0 Enterprise Users Matching Online; Focuses One Million SMEs Market in China
September 13, 2006
HONG KONG, Sept. 13 /Xinhua-PRNewswire/ -- Telecom
Communications, Inc. (OTC Bulletin Board: TCOM), the Total
Solutions Provider, announced today that its subsidiary,
Subaye.com is developing a corporate video sharing channel,
which plans to launch in October.
"We plan to launch a corporate video sharing
channel on Subaye.com called Enterprise Video. This is a
place for business users to engage in new ways with
corporate video, and to show products by sharing,
commenting on, and viewing videos. Enterprise Video will be
originally started as a corporate video sharing service, and
grow into an industries destination with business user
watching videos and matching on the site daily," said
Y.F. Su, vice president of TCOM. "We believe this
value added service will have 100,000 SME members upload
their video and show on Subaye.com during this year
alone."
About Telecom Communications, Inc.
Telecom Communications, Inc. (TCOM) is a Total
Solutions Provider that offers Integrated Communications
Network Solutions and Internet Content Service in universal
voice, video, data web and mobile communications for
interactive media applications, technology and content
leaders in interactive multimedia communications. It
develops, markets and sells a universal media software
solution for enterprise-wide deployment of integrated
voice, video, data web and mobile communications and media
applications. Telecom Communications, Inc. does business in
Asia via its wholly owned subsidiaries, Alpha Century
Holdings Ltd. ( http://www.subaye.com ), IC Star MMS, Ltd.
( http://www.icstarmms.com ), 3G Dynasty Inc. (
http://www.skyestar.com ) and Guangzhou TCOM Computer
Technology Limited.
Safe Harbor
The statements made in this release constitute
"forward-looking" statements, usually containing
the words "believe," "estimate,"
"project," "expect," or similar
expressions. These statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements inherently
involve risks and uncertainties that could cause actual
results to differ materially from the forward-looking
statements. Factors that would cause or contribute to such
differences include, but are not limited to, changing
economic conditions, interest rates trends, continued
acceptance of the Company's products in the marketplace,
competitive factors and other risks detailed in the
Company's periodic report Filings with the Securities and
Exchange Commission. By making these forward- looking
statements, the Company undertakes no obligation to update
these statements for revisions or changes after the date of
this release.
For more information, please contact:
Ms. Sandy Tang
Telecom Communications, Inc.
Tel: +852-782-0983
Email: pr@tcom8266.com
SOURCE Telecom Communications, Inc.
2007'02.10.Sat
Scanner Celebration: Symbol Technologies Announces Sale of One Millionth LS2208 Bar Code Scanner
September 12, 2006
Charlotte Russe to Deploy LS2208 Scanners in 500 Stores
HOLTSVILLE, N.Y., Sept. 12 /Xinhua-PRNewswire/ --
Symbol Technologies, Inc. (NYSE: SBL), The Enterprise
Mobility Company(TM), today announced that it has sold its
one millionth LS2208 bar code scanner further demonstrating
its leadership status in the bar code scanner data capture
market. Symbol also announced the milestone scanner was
purchased by specialty clothing and accessories retailer
Charlotte Russe, who will deploy the LS2208 scanners as
part of a new state-of-the-art point-of-sale (POS) store
front that will be integrated by Symbol partner JDA
software across more than 500 retail locations.
(Logo:
http://www.newscom.com/cgi-bin/prnh/20041029/SYMBOLOGO )
"With increasing demands from customers to
maintain shopper loyalty, we are always looking for new
ways to streamline operations and improve customer
service," said Ed Wong, senior vice president,
Charlotte Russe Stores. "The high-performance Symbol
LS2208 scanner will help to increase employee productivity
and improve customer satisfaction with reduced lines and
faster checkout."
The LS2208 scanner is the fastest selling scanner in
Symbol history and in 2005 its sales represented 33 percent
of all laser scanners sold worldwide(1). With a small,
lightweight and ergonomic design, the LS2208 offers
high-performance scanning designed to increase productivity
at the retail point of sale; improve stockroom operations;
and help track assets and inventory. Its durable design
can withstand up to five-foot drops to concrete and
multiple interfaces provide investment protection for
customers that decide to update their point-of-sale system.
(1) Venture Development Corporation: "The Global
AIDC Industry Business Planning Service 2006," August
2006
"Symbol's LS2208 bar code scanner has been so
successful because of its ability to meet the varying needs
of our customers, such as Charlotte Russe, while offering
increased productivity at an affordable price," said
Bob Sanders, vice president and general manager of Symbol's
advanced data capture division. "This customer
acceptance milestone recognizes Symbol's rich history in
the advanced data capture market and further demonstrates
our commitment to working with channel partners to deliver
best in class bar code scanning solutions."
About Symbol Technologies
Symbol Technologies, Inc., The Enterprise Mobility
Company(TM), is a recognized worldwide leader in enterprise
mobility, delivering products and solutions that capture,
move and manage information in real time to and from the
point of business activity. Symbol enterprise mobility
solutions integrate advanced data capture products, radio
frequency identification technology, mobile computing
platforms, wireless infrastructure, mobility software and
world-class services programs. Symbol enterprise mobility
products and solutions are proven to increase workforce
productivity, reduce operating costs, drive operational
efficiencies and realize competitive advantages for the
world's leading companies. More information is available at
http://www.symbol.com .
For more information, please contact:
Media:
Traci Hoch
Symbol Technologies, Inc.
Tel: +1-631-738-5426
Email: traci.hoch@symbol.com
Financial:
Lori Chaitman
Symbol Technologies, Inc.
Tel: +1-631-738-5050
Email: lori.chaitman@symbol.com
Industry:
Shirley Schroedl
Symbol Technologies, Inc.
Tel: +1-631-738-4823
Email: shirley.schroedl@symbol.com
Joey Marquart
Edelman Public Relations
Tel: +1-212-704-8133
Email: joey.marquart@edelman.com
SOURCE Symbol Technologies, Inc.
2007'02.10.Sat
RNAi Pioneer Craig Mello Named Inaugural Winner of the Dr. Paul Janssen Award for Biomedical Research
September 12, 2006
New Award Honors Dr. Paul Janssen, One of the 20th Century's Most Innovative and Inspiring Pharmaceutical Researchers
BEERSE, Belgium, Sept. 12 /Xinhua-PRNewswire/ --
Johnson & Johnson today announced that Craig C. Mello,
Ph. D., a professor of Molecular Medicine at the University
of Massachusetts Medical School, Worcester, MA, and an
investigator at the Howard Hughes Medical Institute, has
been named the inaugural recipient of The Dr. Paul Janssen
Award for Biomedical Research. Dr. Mello was selected for
his role in the discovery of RNA interference (RNAi) and
the elucidation of its biological functions. The Award will
be presented to Dr. Mello today at The Dr. Paul Janssen
Biomedical Research Scientific Symposium and Award Program
in Beerse, Belgium, which also commemorates the 80th
anniversary of Dr. Janssen's birth.
The Dr. Paul Janssen Award for Biomedical Research was
established by Johnson & Johnson to honor Dr. Paul
Janssen. The Award recipients are chosen by a preeminent
and independent selection committee composed of
world-leading scientists and clinicians. Intending to
acknowledge a scientist whose work has the potential to
make a significant, transformational contribution toward
the improvement of human health, the Award includes a
$100,000 prize and will be given every two years. Dr.
Janssen, who was known to his colleagues as Dr. Paul, was
one of the 20th century's most gifted and passionate
scientists. At the time of his death in 2003, Dr. Paul, who
was the founder of Janssen Pharmaceutica, had contributed to
the discovery and development of more than 80 medicines that
have helped save millions of lives.
"I am very grateful to receive this Award, which
aims to extend the legacy of Dr. Paul Janssen, one of the
greatest scientific innovators of our time," said Dr.
Mello. "I am also very thankful to the Selection
Committee for giving me this Award and to be considered
alongside so many great scientists."
RNA interference is a biological process where
double-stranded RNA inhibits gene expression in a highly
specific fashion. Since its discovery in 1998, RNA
interference has emerged as a powerful
"gene-silencing" technique used in laboratories
around the world to determine which genes are important in
various diseases and conditions. RNAi also has promise as
the basis of gene-silencing therapies. The new field of
RNAi-based genomics is a fundamental paradigm shift for
biomedical research and has the potential to start a
revolution in the development of modern therapeutics.
"Johnson & Johnson is very pleased to award
The Dr. Paul Janssen Award for Biomedical Research to Dr.
Mello," said William C. Weldon, Chairman, Board of
Directors, and Chief Executive Officer of Johnson &
Johnson. "His work and research have the potential to
help millions of people, and this epitomizes the passion,
leadership and innovation that defined Dr. Janssen."
Among Mello's other honors, he has received the 2006
Paul Ehrlich and Ludwig Darmstaedter Prize; the Dr. Lewis
S. Rosenstiel Award for Distinguished Work in Basic Medical
Science; the Gairdner Foundation International Award; the
National Academy of Sciences Award in Molecular Biology;
the Wiley Prize in Biomedical Sciences; the Warren
Triennial Prize, Massachusetts General Hospital; and the
Massry Prize.
"Now more than ever, scientific innovation comes
at a premium," says Sir Richard Sykes, a member of the
Award's international Selection Committee. "Discoveries
such as those by Dr. Mello have the potential to open a
treasure chest of untold medical innovations that can
ultimately help patients on a worldwide basis."
About The Selection Committee
The Award's independent, international Selection
Committee included:
* Dr. Arvid Carlsson (Sweden), University of
Gothenburg, Sweden, 2000
Nobel Laureate in Physiology or Medicine
* Dr. Jean Marie Lehn (France), professor, College de
France, 1987 Nobel
Laureate in Chemistry
* Dr. Hartmut Michel (Germany), director, department of
Molecular Membrane
Biology, University of Frankfurt, 1988 Nobel Laureate
in Chemistry
* Dr. Edward Scolnick (United States), former president
of Merck Research
Laboratories, Merck and Company, now director of the
Psychiatry
Initiative at the Broad Institute, member of the
National Academy of
Sciences, the American Academy of Arts and Sciences,
and the Institute
of Medicine
* Dr. Solomon Snyder (United States), distinguished
service professor of
neuroscience, pharmacology and psychiatry at Johns
Hopkins School of
Medicine, 1978 co-winner of the Albert Lasker Award,
2003 winner of the
National Medal of Science
* Sir Richard Sykes (United Kingdom), former chief
executive officer of
GlaxoWellcome, now Rector of Imperial College,
London, Fellow of the
Royal Society, Honorary Fellow of the Royal Society
of Chemistry, and a
Fellow of the Academy of Medical Sciences
"Dr. Mello is a very deserving recipient of this
auspicious award," said Dr. Snyder. "The
Committee was faced with a very difficult challenge to
select the inaugural recipient for this award. We feel that
Dr. Mello's innovative work opens up new pathways to
understanding basic biology and will have a true impact on
human health."
For more information about the Award, please go to
http://www.pauljanssenaward.com .
About Johnson & Johnson
Johnson & Johnson is the world's most comprehensive
and broadly based manufacturer of health care products, as
well as a provider of related services, for the consumer,
pharmaceutical, and medical devices and diagnostics
markets. The more than 230 Johnson & Johnson operating
companies employ approximately 116,000 men and women in 57
countries and sell products throughout the world.
For more information, please contact:
Seema Kumar
Johnson & Johnson Pharmaceutical Research &
Development, L.L.C.
Tel: +1-908-218-6460
Email: seema@prdus.jnj.com
Frederik Wittock
Johnson & Johnson Pharmaceutical Research &
Development, L.L.C.
Belgium
Tel: +32-14-60-57-24
Email: fwittock@prdbe.jnj.com
Ernie Knewitz
Johnson & Johnson Pharmaceutical Research &
Development, L.L.C.
Tel: +1-908-927-2953
Email: eknewitz@prdus.jnj.com
SOURCE Johnson & Johnson
2007'02.10.Sat
Leadership Change in Air Products' Global Electronics Business
September 12, 2006
New Vice President and General Manager to be Based in Asia
LEHIGH VALLEY, Pa., Sept. 12 /Xinhua-PRNewswire/ -- Air
Products' (NYSE: APD) Electronics business has recently
announced a number of leadership changes, as well as a
strategic decision to locate its global leadership in Asia,
the fastest growing region for the electronics industry.
Corning F. Painter, has been appointed vice president
and general manager, Global Electronics Division, effective
October 1. He will replace Gerald G. Ermentrout who is
retiring after 31 years with Air Products. Painter,
currently regional vice president, Asia Electronics, will
remain in Taiwan and head the division from Taipei.
With this appointment, Air Products' global leaders of
Electronic Specialty Materials, Fab Business Development,
and the Division as a whole will all be based in Asia.
"It is important to be close to our customers, who
should see an increase in the speed of our decision making
as a result," said Painter.
As part of its commitment to Asia markets, Air Products
continues to expand its production facilities in Asia and is
also boosting its research and development presence in the
region with expanded R&D centers in Taiwan and Korea.
"Asia is our largest and fastest growing region
for electronics and it makes sense for the business leader
to be situated there," said Michael F. Hilton, who was
recently appointed vice president and general manager,
Electronics and Performance Materials for Air Products.
"This move is consistent with Air Products' pledge to
be more focused on higher growth and represents our
commitment to Asia." Hilton, currently vice
president, Electronics, will lead the combined
Electronics/Performance Materials organization from the
company's Allentown headquarters.
Ermentrout, who will retire in January, spent the last
15 years in Electronics contributing to the business'
development into an important growth platform for Air
Products. Ermentrout was named general manager,
Electronics in 1992 and elevated to vice president and
general manager in 1996.
Biographies and downloadable photos are available at
http://www.airproducts.com/pressroom/biographies/executivebiographies.htm
About Air Products
Air Products (NYSE: APD) serves customers in
technology, energy, healthcare and industrial markets
worldwide with a unique portfolio of products, services and
solutions, providing atmospheric gases, process and
specialty gases, performance materials and chemical
intermediates. Founded in 1940, Air Products has built
leading positions in key growth markets such as
semiconductor materials, refinery hydrogen, home healthcare
services, natural gas liquefaction, and advanced coatings
and adhesives. The company is recognized for its
innovative culture, operational excellence and commitment
to safety and the environment and is listed in the Dow
Jones Sustainability and FTSE4Good Indices. The company
has annual revenues of $8.1 billion, operations in over 30
countries, and over 20,000 employees around the globe. For
more information, visit http://www.airproducts.com .
***NOTE: This release may contain forward-looking
statements. Actual
results could vary materially, due to changes
in current
expectations.
For more information, please contact:
(Asia)
Jessica Cheng
Tel: +852-2863-0585
Email: chengjs@airproducts.com
(US)
Robert Brown
Tel: +1-610-481-1192
Email: brownrf@airproducts.com
Investor Inquiries:
Phil Sproger
Tel: +1-610-481-7461
Email: sprogepc@airproducts.com
SOURCE Air Products and Chemicals, Inc.
2007'02.10.Sat
Xinhua Far East Upgrades the Issuer Credit Rating of Angang New Steel to BBB+ from BBB
September 12, 2006
HONG KONG, Sept. 12 /Xinhua-PRNewswire/ -- Xinhua Far
East China Ratings today upgraded the issuer credit rating
of Angang New Steel Co., Ltd. ("ANSC" or
"the Company", SZ A 000898; HK 0347) from BBB to
BBB+. Its rating outlook remains stable.
The rating action reflects ANSC's strengthening market
position and marked expansion in production scale following
the acquisition of the remaining steel assets of Anshan Iron
& Steel Group Corporation ("Angang Group").
Consequently, the Company improves both its product
diversification and profitability, allowing it to better
withstand industry cycles. However, ANSC's plans to build
new capacity in the Bayuquan Port will likely raise its
gearing ratio substantially -- a primary factor that
constrains ANSC from obtaining a higher rating.
ANSC's output has almost doubled since its acquisition
of Angang Group subsidiary Angang New Steel & Iron Co.
(`ANSI') and its integration of all remaining Angang Group
steel assets, including upstream products and other end
products. This year, ANSC's steel product production
capacity has risen to more than ten million tons, from six
million tons in 2005. Looking ahead, output should further
increase to 16 million tons, with a new project in the
western district of the Company having commenced operations
earlier this year.
ANSC now owns a complete steel production line and has
expanded its product mix from five categories to ten. The
new project in the western district mainly adds high-end
products, including hot-rolled sheeting, cold-rolled
sheeting and galvanized sheeting, to its overall product
mix. Adding multiple revenue streams is expected to
stabilize the Company's income throughout industry cycles.
The Company's profitability has also been enhanced,
with many of ANSI's end products possessing relatively
high-margins and with a substantial reduction in related
third party transactions between parent and subsidiary.
ANSI's financial results, consolidated since January 2006,
show that in the first half of 2006 ANSC's gross margin and
EBIT margin both rose substantially, to 23.4% and 19.2% from
14.1% and 11.1% respectively in 2005. Iron ore from mines
owned by Angang Group meets about 80% of ANSC's demand and
is sold at a preferential price, a factor which also
contributes to the Company's relatively strong
profitability.
The acquisition was mainly financed through secondary
share offering. Although ANSC is obliged to repay an
additional RMB6.95 billion and interest over three years
from 2006 to 2008, this payment should be manageable, given
the Company's forecasted operating cash inflow of RMB11
billion in 2006.
ANSC plans to build new capacity in Bayuquan Port in
Liaoning Province, which will boost output of a range of
steel products, including steel plating, hot-rolled steel
sheet and cold-rolled steel sheet, by 4.9 million tons
annually. However, this expansion is expected to stretch
the Company's finances and exacerbate its operational and
financial risks in the coming years. The project budget is
RMB22.6 billion, with RMB8 billion of investment scheduled
for this year, RMB12 billion for next year, and the
remaining RMB2.6 billion for 2008. As of the end of June
2006, ANSC's capital commitments already totalled RMB9.15
billion. Xinhua Far East believes that with limited
operating cash flow, ANSC will have to resort to outside
financing, even though its gross debt to total capital
ratio was 34.2% at the end of June 2006. This should push
the ratio up further in the near future.
Building new capacity from scratch and operating on a
much larger scale will also challenge its management
capabilities. ANSC is also exposed to volatility in the
steel market, as well as intensifying competition, with all
key industry players planning to expand their production
scales. Changes in macroeconomic policy could also affect
demand for steel, another factor which could weigh the
Company down.
Even so, Xinhua Far East believes ANSC is in a stronger
position following the acquisition of ANSI, with the planned
new capacity at Bayuquan Port expected to further bolster
its industry position. Xinhua Far East will closely monitor
the funding arrangements for ANSC's new project and consider
any effect on the Company's rating.
ANSC is a major steel producer in China. In 2005, the
Company produced 6 million tons of steel products. After
the acquisition, ANSC's production capacity of steel
products has increased to more than 10 million tons.
Angang New Steel Co., Ltd is also a constituent of the
Xinhua/ FTSE China 200 Index. As of market close on
September 11, 2006, its total market capitalization and
investible capitalization were RMB28.04 billion and RMB5.61
billion respectively.
For the rating report summary, please visit
http://www.xinhuafinance.com/creditrating .
About Xinhua FTSE China 200 Index
Xinhua FTSE China 200 Index is the large cap index in
the Xinhua FTSE China A Share Index Series and includes the
top 200 companies in China by market cap. It is designed as
a tradable index and is calculated in real-time every 15
seconds. For daily data and further information, see
http://www.xinhuaftse.com .
About Xinhua Far East China Ratings
Xinhua Far East China Ratings (Xinhua Far East) is a
pioneering venture in China that aims to rank credit risks
among corporations in China. It is a strategic alliance
between Xinhua Finance (TSE Mothers: 9399), and Shanghai
Far East Credit Rating Co., Ltd. Shanghai Far East became a
Xinhua Finance partner company in 2003 and the first China
member of The Association of Credit Rating Agencies in Asia
in December 2003.
Capitalizing on the synergy between Xinhua Finance and
Shanghai Far East, Xinhua Far East's rating methodology and
process blend unique local market knowledge with
international rating standards. Xinhua Far East is
committed to provide investors with independent, objective,
timely and forward-looking credit opinions on Chinese
companies. It aims to help investors differentiate the
credit risks among the corporations in China, thereby,
cultivating their awareness and promoting information
disclosures and transparency in China market.
For more information, see
http//www.xfn.com/creditrating .
About Xinhua Finance Limited
Xinhua Finance Limited is China's unchallenged leader
in financial information and media, and is listed on the
Mothers board of the Tokyo Stock Exchange (symbol: 9399)
(OTC ADRs: XHFNY). Bridging China's financial markets and
the world, Xinhua Finance serves financial institutions,
corporations and re-distributors through four focused and
complementary service lines: Indices, Ratings, Financial
News and Investor Relations. Founded in November 1999, the
Company is headquartered in Shanghai with 20 news bureaus
and offices in 19 locations across Asia, Australia, North
America and Europe.
For more information, please visit
http://www.xinhuafinance.com .
About Shanghai Far East Credit Rating Co., Ltd
Shanghai Far East Credit Rating Co., Ltd. is the first
and leading professional credit rating company with
comprehensive business coverage in China. It is an
independent agency established by the Shanghai Academy of
Social Sciences with the mission to develop internationally
accepted standards for capital market in China. The company
is a pioneer in conducting bond-rating business in China.
For years, it has been authorized by the Shanghai branch of
the PBOC to undertake loan certificate credit rating.
Since establishment, it has rated over 1,000 corporate
long-term bonds and commercial papers, based on the
principles of objectivity, fairness and independence. The
company has also maintained over 50% market share in the
loan certificate-rating sector in Shanghai for three
consecutive years. With its strong local presence and
knowledge, it provides investors with unique and the most
insightful credit opinion.
For more information, see http://www.fareast-cr.com .
For more Information, please contact:
Hong Kong
Joy Tsang
Corporate & Investor Communiations Director
Xinhua Finance
Tel: +852-3196-3983
+86-21-6113-5999
+852-9486-4364
Email: joy.tsang@xinhuafinance.com
US
Ms. Ishviene Arora
Taylor Rafferty (IR/PR Contact in US)
Tel: +1-212-889-4350
Email: ishviene.arora@taylor-rafferty.com
SOURCE Xinhua Far East China Ratings
2007'02.10.Sat
MIPIM Asia 2006: Close Up On Architecture
September 12, 2006
HONG KONG, Sept. 12 /Xinhua-PRNewswire/ -- Architects
from around the world will converge on Hong Kong this month
to attend the first edition of MIPIM Asia, the international
Asia Pacific property market, which takes place September
27-29 at the Hong Kong Convention and Exhibition Centre.
MIPIM Asia, which will bring together leading companies
involved in the international real estate business, is
proving particularly popular with architecture specialists.
To date, some 50 architecture practices from 19 countries
will be attending the three-day event. Three weeks before
its opening, MIPIM Asia already registered some 1,500 real
estate professionals and 228 exhibiting companies from 42
countries.
"The dynamism of the Asia Pacific real estate
business is generating some truly extraordinary projects
which provide exciting opportunities for architects around
the world," says Gilles Saint Georges Chaumet,
Director of MIPIM Asia. "By bringing together the key
players from Asia Pacific with their international
counterparts, including architects, we hope MIPIM Asia will
contribute to fuelling this dynamism."
Architecture companies attending the show include:
Atkins China Ltd. -- the company has been appointed to
build the TEDA towers in the port of Tianjin. These three
towers will be among China's tallest, with the highest
tower measuring 356 meters and hosting 400 apartments, a
400-room hotel, offices and shopping areas. A total of
400,000 sq. m. of surface area will be created, and the
project is programmed for 2009.
EDAW (Hong Kong) -- is a global, land-based design and
planning consultancy with large-scale projects throughout
the US, Europe, Asia, Australia and the Middle East.
Important public projects in China include the Beijing
Olympic Aquatic Park, the award-winning historical
preservation and tourism development plan for Qiaonan
Village, the large-scale waterfront master plans and
landscape designs for Jinji Lake in Suzhou and Wuxi Li Lake
in Wuxi, and the Macau Cotai resort master plan.
Ong & Ong Architects Ltd. (Singapore) -- founded in
1972, with a track record of more than 500 projects, this
architects practice is widely known in the Asia Pacific
region. Already active in Vietnam, Ong & Ong plans to
start business in Malaysia, India, the Philippines and in
China.
Benoy (United Kingdom) -- an international firm based
in London and Hong Kong, whose projects cover a broad range
of targets, such as retailers, leisure, and more recently
residences, transport and even the renovation of entire
neighborhoods. These projects include Village Renovation
(Hong Kong), Century Boulevard (Shanghai), and APM Kwun
Tong (Hong Kong).
Japan Hayakawa Architectural Design (Japan) -- this
architects practice, widely known for projects that combine
modern design, technology and the environment, was founded
in Tokyo in 1990 and opened a branch in Shanghai in 2004.
Among ongoing projects is the impressive hotel centre
planned for the Shanghai EXPO in 2010.
Archetype Group (Vietnam) -- based in Ho Chi Minh
Ville, the architecture and project management practice is
specialized in designing individual houses and buildings as
well as developing large-scale urban and industrial areas.
In 10 years, Archetype has expanded into Cambodia, India
and Thailand. Their projects include Saigon Pearl
Residential Towers, Bodhi Tree Resort, Lafarge Cement
Factory, Trung Yen Luxury apartment, and the British
Embassy.
AEDAS (Hong Kong) -- operating in the United Kingdom,
China, Malaysia, Hong Kong and Singapore, this organisation
specialised in architecture, design and urban planning is
highly focused on environmental issues. Large-scale
projects include North Star (Beijing) and West Kowloon
Cultural district (HK).
Woodhead (Australia) -- this famous firm of architects
is competing for the creation of a new urban district --
Diamond Island -- in Ho Chi Minh Ville (Vietnam). Other
ongoing projects include Chongqing Fortune Plaza involving
the design of several hotels and apartments covering
100,000 sq. m. in Chongqing in China, and Beijing Olive
Town, an over-56,000 sq. m. shopping area in the Chinese
capital.
KOW (Netherlands) -- one of the major independent
architects firms in Holland which also delivers
communication solutions for the real estate sector and is
now developing in the Asia Pacific region. One of its
hallmarks is adapting techniques and materials to highly
eclectic projects such as an electricity generating plant,
and a 5-star hotel in Chengdu (China) covering 100,000 sq.
m.
MIPIM Asia is organising a theme lunch on architecture
in partnership with Benoy. It will take place on Wednesday
27 September at 12.15 p.m.
Check the full list of exhibitors at
http://www.mipimasia.com .
For more information, please contact:
Ms Belinda Chan
Tel: +852-2372-0090
Email: belinda@creativegp.com
SOURCE Reed MIDEM
2007'02.10.Sat
Personal Video Recording (PVR) Goes Mobile with Technology from Texas Instruments
September 12, 2006
Together With PacketVideo and S3, TI's Hollywood(TM) + OMAP(TM) Solution Enables Delivery of PVR and Picture-in-Picture Functionality to DVB-H Mobile Phones
AMSTERDAM, Sept. 12 /Xinhua-PRNewswire/ -- Television viewers have become addicted to conveniently accessing their favorite shows with personal video recording (PVR) technology. Soon consumers will be able to extend this "on demand" living room experience to their mobile devices with PVR capabilities enabled by Texas Instruments Incorporated (TI) (NYSE: TXN) technology. This week at IBC, TI, with partners PacketVideo and Silicon & Software Systems Ltd. (S3), will showcase advanced mobile DTV solutions. The demonstrations of TI's Hollywood(TM) DVB-H single chip and OMAP(TM) 2 platform include the industry's first mobile PVR and picture-in-picture (PIP) functionality using PacketVideo's pvTV(TM) technology over a live DVB-H network. (Visit http://www.ti.com/mobiletv for more information.) The new mobile PVR and PIP solution will nurture increased viewing of mobile DTV content as consumers will have access to the programming they are most interested in viewing, without having to rely on "tuning in" to a live programming schedule. Initial mobile DTV usage indicates consumers will spend up to three hours per day watching mobile TV content, broken into short "snack-sized" viewing segments of two to 10 minutes at a time. Morning and evening commutes, lunch breaks and early evening are expected to be prime viewing times for mobile DTV users. These added capabilities would allow increased flexibility to what content the consumer views during their viewing times instead of being bound to what is on at that moment. DVB-H mobile DTV networks provide the spectral efficiency and flexibility needed to meet the demands of content-hungry consumers. "Consumers are hooked on personalized content, with consumer adoption for personal video recording growing at exponential rates. TI's work with partners PacketVideo and S3 is critical to delivering consumer electronics functionality to mobile handsets, including PVR and PIP. These advanced features give users access to their personalized content anytime, anywhere, in the palms of their hands," said Marc Cetto, general manager of TI's Mobile Connectivity Solutions business. With the Hollywood chip (DTV1000) and OMAP processor-based solution, consumers can watch live TV and store broadcast content on their mobile devices. Coupled together, the OMAP2430 processor and TI's Hollywood single chip provide the most advanced overall solution for the reception, decoding and processing of TV content to mobile phones. The PIP capability can showcase two live channels of content - ideal for users who want to preview other channel programming or even sports fans who want to watch multiple events at once. It can also work with the PVR for users who may also view one channel showcasing personalized, pre-recorded content like a movie, while the other channel plays live broadcast content such as weather or financial market updates. Road warriors can take advantage of the video-out capability of OMAP processors and display their personalized content on a TV either at home or while traveling. The PVR and PIP demonstration uses PacketVideo's pvTV client solution -- a complete mobile digital TV client platform based on PacketVideo's proven video player framework. PacketVideo's pvTV solution for DVB-H has two components: the pvTV client software, and the pvTV reference hardware platform. Additionally at IBC, TI will showcase an OMAP2420 mobile DTV solution, which also integrates S3's onHandTV(TM) DVB-H middleware. The onHandTV solution delivers a robust, proven middleware platform for mobile TV applications. The demonstration will showcase a DVB-H Group C broadcast stream at up to 30 frames per second, supported by the PacketVideo framework. The S3 solution is also designed to enable PVR and PIP functionality. TI's OMAP 2 processors deliver low-power, high-performance multimedia processing to enable mobile DTV solutions with the kind of high-end user experience consumers expect while watching TV at home. Decoding two channels simultaneously is only possible with a robust applications engine such as the OMAP2430 processor, which can decode TV channels "on the fly" and display both channels at the same time. TI's OMAP processors have been integral in defining mobile entertainment and are used in high-quality mobile video applications to deliver high performance and power efficiency, allowing handset manufacturers to bring the entertainment center to the handset. As the industry's first single-chip DVB-H solution, TI's Hollywood chip offers significant advantages in solution size, bill of materials and power consumption to drive mobile digital TV into mass market phones and devices. The Hollywood chip can be used for mobile DTV-enabled personal media players, and provides an integrated tuner, demodulator, decoder and memory on one piece of silicon. For this type of PVR and PIP application, the DVB-H receiver (such as DTV1000), must be able to process multiple services, such as two TV channels simultaneously (concurrently or back-to-back) without increasing system memory cost and footprint. TI's partners play an important role in delivering innovation around the Hollywood chip-based DVB-H solution. TI works with PacketVideo, S3 and a number of other companies in the mobile DTV ecosystem to provide an end-to-end solution for mobile DTV while enabling choices for handset manufacturers. In January 2006, TI was one of the co-founders of the Mobile DTV Alliance, which is focused on promoting mobile digital TV and accelerating DVB-H development and deployment in North America. The Alliance's founding members include Intel, Microsoft, Modeo, Motorola, Nokia and TI. Availability Consumer access to PVR and PIP capabilities on DVB-H handsets is expected in 2007. Manufacturers interested in technology behind TI's IBC mobile TV demonstrations can visit TI at http://www.ti.com/mobiletv , PacketVideo at http://www.packetvideo.com or S3 at http://www.s3group.com . Texas Instruments -- Making Wireless TI is the leading manufacturer of wireless semiconductors, delivering the heart of today's wireless technology and building solutions for tomorrow. TI provides a breadth of silicon and software and over 15 years of wireless systems expertise that spans handsets and base stations for all communications standards, wireless LAN, Bluetooth, A-GPS, mobile TV and Ultra Wideband. TI offers custom to turn-key solutions, including complete chipsets and reference designs, OMAP(TM) application processors, as well as core digital signal processor and analog technologies built on advanced semiconductor processes. Please visit http://www.ti.com/wirelesspressroom for additional information. About Texas Instruments Texas Instruments Incorporated provides innovative DSP and analog technologies to meet our customers' real world signal processing requirements. In addition to Semiconductor, the company includes the Educational & Productivity Solutions business. TI is headquartered in Dallas, Texas, and has manufacturing, design or sales operations in more than 25 countries. Texas Instruments is traded on the New York Stock Exchange under the symbol TXN. More information is located on the World Wide Web at http://www.ti.com . Safe Harbor Statement Statements contained in this news release regarding TI product availability and other statements of management's beliefs, goals and expectations may be considered forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. The following factors and the factors discussed in TI's most recent Form 10-K could cause actual results to differ materially from the statements contained in this news release: actual market demand for TI products specifically, and actual test results relating to TI products. TI disclaims any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this news release. Trademarks OMAP and Hollywood are trademarks of Texas Instruments. All other trademarks and registered trademarks are the property of their respective owners. For more information, please contact: Daniela Koeppe (EMEA) tel: +33-493-22-2947 Email: koe@ti.com Tracy W. Steiner (USA) Tel: +1-214-480-7487 Email: t-wright@ti.com SOURCE Texas Instruments Incorporated
2007'02.10.Sat
SoyLink(R) Receives Breakthrough Patent on Soy Powder Processing
September 12, 2006
Breakthrough Technology on Micromilling and Deflavoring Soy Protein Powders
SIOUX FALLS, S.D., Sept. 12 /Xinhua-PRNewswire/ --
SoyLink(R), a limited liability company in Oskaloosa, Iowa,
and subsidiary of the Broin Companies, announced today that
the company has been issued a patent through the United
States Patent and Trademark Office that covers proprietary
technology used to produce SoyLink's line of highly
functional soybean protein powders. The patent, US
7,097,871 B2 entitled "Deflavored Vegetable Powders,
Methods of Making Them, and Systems for Vegetable
Milling," includes methods to deflavor soybeans as
well as milling them to the smallest particle size
commercially available in the industry. The technology
increases the scope of soybeans in the food industry when
compared to conventional soy powders.
"SoyLink sees this as the technology of the future
for soy processing operations," Dr. Noel Rudie,
SoyLink's Vice President for Research and Operation says.
"This is truly a win-win situation. Because we produce
a whole bean product, the consumer gets soy milk with all of
the benefits of soy including natural soy fiber. At the same
time, the food processor benefits by eliminating the okara
waste stream commonly found in the conventional process,
allowing for higher yields."
The patented technology includes methods for removing
the undesirable flavor from soybeans, making them more
acceptable to consumers. Soy flours have seen limited
acceptance in the manufacture of soy milk and other dairy
analogues in some markets because of the beany flavor and
chalky texture they develop. SoyLink technology addresses
both of these objections, first by removing the
objectionable beany flavor before the powders are milled to
a small particle size (less than 30 microns) that allows the
soy beverage manufacturer to produce products without the
chalky texture.
The small particle size benefits manufacturers of soy
beverages because it allows them to use the whole bean
powder. In addition to soy beverages, the SoyLink powders
can be used in tofu, pasta, baked products, soynut butter,
nutrition bars, and a large variety of other applications
requiring either a deflavoring technology or small particle
size. Both organic and Non-GMO powders in various mesh sizes
are available.
"The team at SoyLink is very excited about the
industry's response to this technology," Dr. Rudie
says. "With its patented deflavoring technology and
great functionality, imagination is the only limit on what
applications can be developed using these soy
powders."
Started in 2002, SoyLink produces a proprietary line of
soy powders with improved functionality for the food
industry. SoyLink home offices include a manufacturing
site, as well as the location of the business offices,
research laboratories, and product development facilities.
For more information, please contact:
Mike Lockrem
Broin Companies
Tel: +1-605-965-6428
Email: mike.lockrem@broin.com
Web: http://www.broin.com
SOURCE Broin Companies
2007'02.10.Sat
A Series of Selection Work Like'Best Chinese and Foreign Cities to be Invested by Chinese and Foreign Enterprises' is Well Underway
September 11, 2006
BEIJING, Sept. 11 /Xinhua-PRNewswire/ -- To promote the
implementation of China's strategy of bringing in foreign
enterprises to invest in China and encouraging Chinese
enterprises to make investment overseas, the Organizing
Committee of the World Economic Development Declaration,
the Global Compact Office of the United Nations and United
Nations Environment Programme have sponsored the
competition to select the ` Best Chinese Cities/
Development Zones to be Invested in by Multinational
Corporations during the 11th Five-Year Program in China', `
Top 100 Multinational Corporations in China and Top 100
Chinese Enterprises with Utmost Core Competitiveness', and
` Best Foreign Cities/ Development Zones to be Invested in
by Chinese Enterprises'. China International Institute of
Multinational Corporations and Global Times Newspaper in
China will hold the competition with Xinhua PR Newswire
(XPRN) as its official global news release distributor.
The results of this competition will help multinational
corporations to choose the best Chinese cities and
development zones for investment, as well as help Chinese
cities and development zones to choose multinational
corporations in China and Chinese enterprises with utmost
core competitiveness to cooperate with. Similarly, it will
help Chinese enterprises to choose better cities and
development zones for their overseas development. The
selection result will have important and realistic
significance as well as far-reaching historic significance
on the future cooperation and development of Chinese and
foreign cities, enterprises and development zones.
Along with the announcement of the selection results
and an Awards ceremony, the sponsors will hold a grand
Round-Table Meeting of Chinese and Foreign Mayors,
Presidents of Banks and CEOs. At that time, Chinese state
leaders, leaders from ministries and commissions,
ambassadors and commercial counsellors of relevant
countries in China, presidents of all foreign chambers of
commerce in China and mainstream Chinese and foreign media
will be invited.
In the course of the Round-Table Meeting and Awarding
Ceremony, selected Chinese and foreign cities, development
zones and enterprises can deliver their propaganda
materials, introductions of cooperation projects, policies
of attracting investment and regulations. The sponsors will
promote the cooperation and exchange among Chinese and
foreign cities, development zones and enterprises by way of
dialogues, communications and private meetings. After the
meeting, all delegates will obtain a valuable directory of
contact details. Furthermore, a series of promotion
activities will be carried out during `The 11th Five-Year
Program' with the purpose of creating greater business
opportunities and cooperation chances for the awardees.
About China International Institute of Multinational
Corporations (CIIMC)
Founded on January 1, 1993, the CIIMC is an
international platform for promoting the exchange and
cooperation between Chinese and foreign enterprises. In
more than ten years, CIIMC, joining with related ministries
and commissions, provinces and municipalities, renowned
Chinese and foreign media, related international
organizations foreign chambers of commerce and
multinational corporations concerned, has held such
large-scale activities as the "Seminar of Enterprise
Quality Strategy for Chinese Brand Products",
"Economic and Trade Talks of Sino-US Large-Scale
Enterprises", "Talks on Sino-Japan Economic
Exchange", "WTO and China" and
"Information Industry and Global Economy",
"The World Economic Development Declaration
Conference", and "High Level International
Conference on Millennium Development Goals".
About Xinhua PR Newswire (XPRN)
Xinhua PR Newswire is a joint venture by PR Newswire in
New York and Xinhua Finance in Hong Kong. It provides
electronic distribution, targeting, measurement,
translation and broadcast services on behalf of some 40,000
corporate including more than 300 of the world's 500 top
companies, government, association, labor, and non-profit
clients. Using PR Newswire, companies reach a variety of
critical audiences including the news media, the investment
community, government decision-makers, and the general
public. Established in 1954, PR Newswire has offices in 11
countries and routinely sends its customers' news to
outlets in 135 countries and in 40 languages. Xinhua
Finance Limited is China's unchallenged leader in financial
information and media. Bridging China's financial markets
and the world, it serves financial institutions,
corporations and re-distributors through four focused and
complementary service lines: Indices, Ratings, Financial
News and Investor Relations.
For more information, please contact:
Professor Xiaoyu Zhang
Executive Vice-President & Secretary-General
CIIMC
Tel: +86-10-8766-5158
Email: zhangxiaoyu@wedd.org
Mr. Yi Yang
Media Relations Executive
Xinhua PR Newswire China
Tel: +86-10-5864-5304
Email: yi.yang@xprn.com
SOURCE China International Institute of Multinational
Corporations (CIIMC)
2007'02.10.Sat
New Website Looks at the Science Behind Stroke
September 11, 2006
http://www.novelneuroprotection.com Aims to Increase Understanding of Acute Ischemic Stroke and the Potential Role of Neuroprotection
MACCLESFIELD, England, Sept. 11 /Xinhua-PRNewswire/ -- A new resource for the international medical community was launched in September 2006 by AstraZeneca, http://www.novelneuroprotection.com . This educational site aims to help healthcare professionals understand more about acute ischemic stroke and the potential therapeutic approach of neuroprotection. Dr. Tomas Odergren, Global Product Director, AstraZeneca commented, "Around a third of the 15 million people worldwide who suffer a stroke each year are left permanently disabled. There are relatively few treatment options available for acute stroke patients. Neuroprotectants are a new class of drugs in development to treat this life-shattering condition. This website is designed to help stroke specialists and other healthcare professionals understand the science behind neuroprotection and the latest advances in technology." The site includes key information on the effects of cerebral ischemia, which occurs when a blood vessel in the brain is blocked during a stroke. Cerebral ischemia triggers a series of biochemical events known as the ischemic cascade. This results in the death of brain cells, or neurons, in the core affected area of the brain. In addition, neurons are injured in the wider surrounding area, known as the ischemic penumbra. Neuroprotectants are thought to help preserve brain cells in the ischemic penumbra by interfering with the damaging events of the ischemic cascade. In a series of short articles, the web site explains these changes which take place at the cellular and molecular level. Details of how neuroprotectants are thought to interfere with these events and could potentially offer improved outcomes for stroke patients are also discussed. With the stroke image atlas, healthcare professionals have access to over 750 high-quality images that are accompanied by detailed explanatory text. It provides a visual and practical insight into the etiology, diagnosis, and management of stroke. In addition, http://www.novelneuroprotection.com is interactive and features constantly updated stroke news, a calendar of stroke events, key international meetings and links to relevant PubMed articles. Alternatively visit http://www.astrazenecapressoffice.com Notes to Editors: -- AstraZeneca is currently developing NXY-059, an investigational drug for treatment of stroke, licensed from Renovis, Inc. NXY-059 has a proposed mechanism of action of free radical trapping and is being studied as a neuroprotectant in clinical trials based on positive effects seen in experimental models of acute ischemic stroke. -- The SAINT trials for NXY-059 are being conducted worldwide in approximately 400 centres across 40 countries to evaluate the effect of the compound in acute ischemic stroke patients. These countries and regions include: Europe, Asia, Australia, New Zealand, South Africa, United States, Canada and Latin America. SAINT II is due to report in the first half of 2007. -- NXY-059 was previously referred to as 'Cerovive.' NXY-059 will be used from this point forward until a global trademark has been approved. -- A preliminary analysis of SAINT I was first presented at the European Stroke Congress in May 2005. -- CHANT (Cerebral Hemorrhagic And NXY-059 Treatment) is a double-blind, randomized, placebo-controlled, parallel-group, multi-center, phase IIb study to assess the safety and tolerability of NXY-059 in adult patients with acute intracerebral hemorrhage. This study is complete and is due to report in Q1 2006. About AstraZeneca AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of over $21.4 billion and leading positions in sales of gastrointestinal, cardiovascular, respiratory, oncology and neuroscience products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index. In Neuroscience, AstraZeneca markets several products including SEROQUEL(R), one of the fastest growing global antipsychotics and ZOMIG(R), a migraine therapy and a leader within the global triptan market. The Neuroscience pipeline includes investigational compounds for the treatment of depression and anxiety, overactive bladder, dementia, stroke, pain control and anaesthesia. For more information, please contact: Virginie Bousquet AstraZeneca Tel: +44-162-551-7831 Email: Virginie.Bousquet@astrazeneca.com Nii Turkson Porter Novelli Tel: +44-207-853-2237 Fax: +44-207-853-2244 Email: Nii.Turkson@porternovelli.co.uk SOURCE AstraZeneca
2007'02.10.Sat
WHO Publishes Third Edition of its Guidelines for the Safe Use of Wastewater, Excreta And Greywater
September 11, 2006
BEIJING, Sept. 11 /Xinhua-PRNewswire/ -- In many parts
of the world, good quality fresh water resources are
becoming increasingly scarce. At the same time, wastewater
is produced in ever-larger quantities, mainly as a result of
the continued growth of the human population and the process
of rapid urbanization. In reality, wastewater is a water
resource of ever-growing importance, particularly for the
urban and peri-urban poor whose livelihoods depend on
agricultural products that can be marketed locally.
However, its use for crop and fish production carries
important health risks and the disease burden that can be
attributed to its unsafe use is considerable.
(Logo:
http://www.newscom.com/cgi-bin/prnh/20040610/CNTH001LOGO )
The third edition of the WHO Guidelines for the Safe
Use of Wastewater, Excreta and Greywater in Agriculture and
Aquaculture is published in four volumes, addressing,
respectively, policy and regulatory aspects, wastewater use
in agriculture, wastewater and excreta use in aquaculture
and excreta and greywater use in agriculture. It
supersedes the second edition of the guidelines, which was
published in 1989.
"This third edition of the Wastewater Guidelines
marks an important departure from the previous
edition," says Susanne Weber-Mosdorf, Assistant
Director-General for the Cluster of Sustainable Development
and Healthy Environments. "The rigid and prescriptive
character of the second edition has evolved to a more
contemporary and flexible approach based on scientific
evidence and process-oriented risk assessment and
management. The Guidelines reflect a strong focus on
disease prevention and public health principles. Water
quality regulators will have to work towards attaining
health-based targets through an integrated approach."
Parallel to this new thinking on handling risks in an
integrated manner, the guidelines also reflect new thinking
in the field of sanitation. This has evolved in part in
response to the sanitation target within the Millennium
Development Goals. Volume 4 of this third edition
elaborates on this issue and the links to safe use of
excreta and greywater in agriculture.
"Eco-sanitation is scaling up from a stage of
pilot studies to extensive use in a number of countries,
for example China and South Africa," says Professor
Thor Axel Stenstroem who holds positions at the Swedish
Institute for Infectious Disease Control and the Stockholm
Environment Institute. "Now, for the first outcomes
of a recently initiated WHO/Sida study provides proof of a
significantly reduced health impact. In a comparative
study, the Nelson Mandela School of Medicine of the
University of KwaZulu Natal (Durban) and the Ethekwini
Municipality measured the incidence of diarrhoea, vomiting,
skin infections and worms in six cohorts of a total of more
than 7000 people from 1337 households. The study now
provides evidence of significant correlations between
disease outcome in relation to sanitation interventions,
outcomes for disease per area, incidence rates of health
outcome and incidence rate ratio of disease outcome."
The guidelines clearly reflect regional differences in
wastewater use and in associated public health issues. For
example, the use of wastewater and excreta in aquaculture in
SE Asia brings with it region-specific risks, such as the
transmission of food-borne trematodes. These parasitic
flukes have a complex life cycle that involves aquatic
snails and fish as intermediate hosts; water bodies are
contaminated by human excreta containing the parasite's
eggs. Consumption of raw or fermented fish -- a common
practice in rural communities of SE Asia -- from infected
ponds closes the infection cycle.
The burden of disease caused by infections with
food-borne trematodes is considerable: globally, an
estimated 40 million people are at risk. Recent studies
indicate that in China alone over the period 1995-2004 the
incidence of one of the various parasitic infections in
this group, clonorchiasis, tripled -- some 15 million
Chinese were estimated to be infected with Clonorchis
sinensis in 2004. A large part of this disease burden is
thought to be attributable to excreta and greywater use in
fishponds.
The WHO Guidelines for the Safe Use of Wastewater,
Excreta and Greywater in Agriculture and Aquaculture
reflect the knowledge and experience of a unique group of
scientists, regulators and public health specialists
brought together by the Water, Sanitation and Health
Programme of the World Health Organization. The next step
will be their implementation by WHO Member States. To
study the obstacles and opportunities that may be
encountered in their application and use, WHO and the
Canadian International Development Research Centre shortly
will start joint research in three countries in North and
/or West Africa.
The Guidelines are available online at:
http://www.who.int/water_sanitation_health/wastewater/gsuww/en/index.html
If you haven't already replied but would like to attend
the launch of the World Health Organization (WHO) Guidelines
for the Safe Use of Wastewater, Excreta and Greywater in
Agriculture and Aquaculture in Beijing at 13:00 on Tuesday
September 12, please contact Elizabeth Loughnan:
Elizabeth Loughnan
WHO China
Tel: +86-1361-117-4072
Email: ElizabethL@chn.wpro.who.int
For more information, please contact:
Africa
WHO Regional contact for Water, Sanitation and Health
in Africa:
Dr Ahmed Nejjar
Environmental Health Officer
WHO Regional Office for Africa in Brazzaville, Congo.
Tel: +47-241-39271
Email: nejjars@afro.who.int
The Americas
WHO Regional contacts for Water, Sanitation and Health
in the Americas:
Mr Luiz Augusto Cassanha Galvao
Manager, Sustainable Development and Environmental
Health Area
WHO Regional Office for the Americas, Washington DC,
USA.
Tel: +1-202-974-3156
Email: galvaolu@paho.org
Dr Mauricio Pardon
Director CEPIS, Lima, Peru
Email: mpardon@cepis.ops-oms.org
Eastern Mediterranean Region
WHO Regional contacts for Water, Sanitation and Health
in the Eastern
Mediterranean:
Dr Houssain Abouzaid
Coordinator, Healthy Environments, WHO Regional Office
for the Eastern
Mediterranean, Cairo, Egypt.
Tel: +20-2676-5028 (operator)
+20-2279-5362 (direct)
Email: she@emro.who.int
Dr M.Z. Ali Khan
Director, WHO/EMRO Centre for Environmental Health
Activities, P.O. Box
926769, Amman, Jordan.
Tel: +962-6-552-4655
Email: ceha@ceha.emro.who.int
Europe
WHO Regional contact for Water, Sanitation and Health
in Europe:
Mr Roger Aertgeerts, Regional Adviser, Water and
Sanitation, WHO
Regional Office for Europe, Centre for Environmental
Health, Rome, Italy.
Tel: +39-064-877-528
Email: rae@who.it
South East Asia and the Western Pacific
WHO Regional contact for Water, Sanitation and Health
for South and part
of South East Asia:
Dr Han Heijnen
Senior Adviser Water and Sanitation, WHO Regional
Office for South-East
Asia, based at the WHO Office Kathmandu, Nepal.
Tel: +977-1-552-3993
Email: hanheijnen@gmail.com
WHO Regional contact for Water, Sanitation and Health
for part of South
East Asia and the Western Pacific:
Dr Terence Thompson
WHO Regional Office for the Western Pacific, Manila,
Philippines.
Tel: +63-2-528-8001
Email: thompsont@wpro.who.int
National Technical Experts available for interviews.
This list of experts contains the names and coordinates
of some of those who have contributed substantially to the
third edition of the Guidelines:
Peter Edwards
Emeritus Professor
Asian Institute of Technology
Home address:
593 Soi Lad Prao 64
Bangkok 10310, Thailand
Tel: +66-2-538-6551
Fax: +66-2-530-0660
Email: pedwards@inet.co.th
pedwards@ait.ac.th
Blanca Jimenez
Universidad nacional autonoma
Apdo Postal 70472
Ciudad Universitaria
04510 Coyoacan DF
Mexico
Tel: +52-55-5623-3600 x8684
Fax: +52-55-5623-3600 x8055
Duncan Mara
University of LEEDS
School of Civil Engineering
University of Leeds
Leeds LS2 9JT
West Yorkshire
UK
Tel: +44-113-343-2276
Fax: +44-113-343-2243
Professor Hillel Shuval D.Sc.
Kunen-Lunenfeld Emeritus Professor of Environmental
Sciences
The Hebrew University
Jerusalem
Israel
Tel/Fax: +972-2-566-0429
Email: hshuval@vms.huji.ac.il
Professor Thor Axel Stenstroem
Swedish Institute for Infectious Disease Control
Lundagatan 2
105 21 Stockholm
Sweden
Tel: +46-8-457-2469
Fax: +46-8-730-3248
SOURCE World Health Organization
2007'02.10.Sat
Corning CEO to Address Investors at Citigroup Technology Conference
September 11, 2006
Stronger LCD Glass Volume and Financial Performance Expected in Third Quarter
CORNING, N.Y., Sept. 11 /Xinhua-PRNewswire/ -- Corning
Incorporated (NYSE: GLW) President and Chief Executive
Officer Wendell P. Weeks will address investors at the
Citigroup 13th Annual Global Technology Conference in New
York, Sept. 6. Weeks will provide an update to the
company's third-quarter guidance.
Weeks will tell investors that the company has narrowed
the guidance range for sequential liquid crystal display
(LCD) glass volume growth for its wholly owned Display
Technologies business to up 10 to 15 percent from the
previous guidance of up 5 to 15 percent. Additionally, he
will provide a narrowed guidance range for sequential LCD
glass volume growth at Samsung Corning Precision Co., Ltd.
of up 8 to 12 percent from the previous guidance range of
up 5 to 15 percent.
Weeks will also present a revised third-quarter
earnings per share (EPS) guidance range of $0.24 to $0.26,
narrowed from the previous range of $0.22 to $0.26. This
EPS estimate is a non-GAAP financial measure and excludes
any possible special items. This and all non-GAAP
financial measures are reconciled on the company's investor
relations Web site and in an attachment to this news
release.
The company also revised its third-quarter sales
guidance range to $1.27 billion to $1.31 billion from the
previous $1.26 billion to $1.33 billion. Weeks will explain
that this change reflects updates to LCD sales estimates and
foreign currency translation rates. Also, the company's
gross margin guidance range has been narrowed to 42 to 43
percent from the previous 41 to 43 percent. Guidance ranges
for other businesses remain unchanged.
"We are encouraged by the results we have seen in
our Display Technologies segment over the last two months.
Supply chain improvements as well as a sequential increase
in glass demand from our customers have led us to a more
optimistic view of quarter three. And, our end market
analysis indicates that demand for LCD notebooks, monitors
and TVs continues to meet our expectations at the retail
level," Weeks will say.
Weeks will outline key indicators of improved health in
the display industry supply chain that have contributed to
the company's improved outlook for the quarter. These
include: normal end market seasonality; reductions in panel
inventory levels; and increased panel manufacturing
utilization rates, particularly for the Taiwanese panel
manufacturers.
Looking forward to the remainder of 2006, Weeks will
add, "We believe that normally stronger seasonal
demand for both monitors and TVs as well as supply chain
replenishment will allow the overall LCD glass market
volume to grow between 40 and 50 percent this year."
Corning's presentation to investors at the Citigroup
13th Annual Global Technology Conference will be available
via webcast by accessing the IR events calendar on
Corning's Web site at
http://www.corning.com/investor_relations .
Corning executives will also be presenting at the Bank
of America Annual Investment Conference in San Francisco on
Sept. 20, 2006.
Presentation of Information in this News Release
Non-GAAP financial measures are not in accordance with,
or an alternative to, GAAP. Corning's non-GAAP EPS measure
excludes restructuring, impairment and other charges and
adjustments to prior estimates for such charges.
Additionally, the company's non-GAAP measure excludes
adjustments to asbestos settlement reserves required by
movements in Corning's common stock price, gains and losses
arising from debt retirements, charges resulting from the
impairment of equity or cost method investments, or
adjustments to deferred tax assets, and gains or losses
recognized in equity earnings from restructuring,
impairment or other charges or credits taken by equity
method companies. The company believes presenting non-GAAP
EPS measures are helpful to analyze financial performance
without the impact of unusual items that may obscure trends
in the company's underlying performance. These non-GAAP
measures are reconciled on the company's Web site at
http://www.corning.com/investor_relations and accompany
this news release.
About Corning Incorporated
Corning Incorporated ( http://www.corning.com ) is a
diversified technology company that concentrates its
efforts on high-impact growth opportunities. Corning
combines its expertise in specialty glass, ceramic
materials, polymers and the manipulation of the properties
of light, with strong process and manufacturing
capabilities to develop, engineer and commercialize
significant innovative products for the telecommunications,
flat panel display, environmental, semiconductor, and life
sciences industries.
Forward-Looking and Cautionary Statements
This press release contains forward-looking statements
that involve a variety of business risks and other
uncertainties that could cause actual results to differ
materially. These risks and uncertainties include the
possibility of changes in global economic and political
conditions; tariffs, import duties and currency
fluctuations; product demand and industry capacity;
competition; manufacturing efficiencies; cost reductions;
availability and costs of critical components and
materials; new product development and commercialization;
order activity and demand from major customers; changes in
the mix of sales between premium and non-premium products;
facility expansions and new plant start-up costs; possible
disruption in commercial activities due to terrorist
activity, armed conflict, political instability or major
health concerns; adequacy and availability of insurance;
capital spending; equity company activities; acquisition
and divestiture activities; the level of excess or obsolete
inventory; the rate of technology change; the ability to
enforce patents; product and components performance issues;
stock price fluctuations; and adverse litigation or
regulatory developments. Additional risk factors are
identified in Corning's filings with the Securities and
Exchange Commission. Forward-looking statements speak only
as of the day that they are made, and Corning undertakes no
obligation to update them in light of new information or
future events.
For more information, please contact:
Media Relations Contact:
Corning China
Lydia Lu
Tel: +86-21-5467-4666 x1900
Email: lulr@corning.com
US Corning
M. Elizabeth Dann
Tel: +1-607-974-4989
Email: dannme@corning.com
Investor Relations Contact:
Kenneth C. Sofio
Tel: +1-607-974-7705
Email: sofiokc@corning.com
SOURCE Corning Incorporated
広告
ブログ内検索
アーカイブ
カウンター